Medical Courier Market Outlook Report | 2020-2030
[研究报告] 2022 年医疗快递市场规模价值 73.052 亿美元,预计到 2030 年将达到 109.6443 亿美元。预计 2022-2030 年期间的复合年增长率为 5.2%。
市场洞察和分析师观点:
由于医疗快递数量的增加,对医疗样本、紧急情况下血液和血液样本的运输的需求不断增长,以及对药品送货上门的倾向性很高,医疗快递市场规模正在快速增长。
医学领域,尤其是诊断实验室服务领域正在发生巨大的进步,革命性的技术也在以稳定的速度被发现,吸引了大量的人从事这一行业,从而推动诊断实验室服务市场获得无限的增长。许多人逐渐意识到,在了解和治疗特定疾病方面,高质量的诊断服务能带来巨大的好处。由于这种增长,这些实验室分析的样本数量也随之增加,这需要及时提供样本和报告。因此,诊断实验室的发展和全球数量的增加是推动市场增长的因素。
增长动力和挑战:
根据国际糖尿病联合会 2021 年的数据,每 11 名成年人中就有 1 人患有糖尿病,即 6100 万人。欧洲患有 1 型糖尿病的儿童和成人人数最多,为 29.5 万人。年龄调整后糖尿病患者(20-79 岁)患病率排名前 5 的国家是土耳其、西班牙、安道尔、葡萄牙和塞尔维亚。
根据由阿斯利康资助和发起的《经济学人影响力》白皮书,慢性肾病 (CKD) 影响着欧洲约十分之一的成年人。据估计,欧洲有 1 亿人患有这种长期、渐进性疾病,到 2023 年,将有另外 3 亿人面临风险。根据 CDC 的数据,到 2023 年,美国约有 3550 万人(约占总人口的 14%)患有 CKD。
前列腺癌 (PCa) 是男性最常见的非皮肤癌症之一。由于近期治疗方面的各种改进,预计欧盟 (EU) 的前列腺癌死亡率将下降。欧洲的 PCa 发病率高于非洲或亚洲等其他地区,这是因为欧洲的前列腺特异性抗原 (PSA) 筛查率相对较高,据报道东欧和南欧的筛查率正在上升。活检有助于癌症检测,活检时会从可能存在癌症的身体部位取少量组织,然后将该组织送往实验室。
因此,全球糖尿病、CKD和癌症等慢性病病例的增加,同时推动了对医疗用品的需求,并对医疗快递市场的增长产生了积极影响。
货物交付延迟可能会导致快递公司失去客户。这还可能增加整体运输成本,导致客户不满意和高退货率 (RTO)。例如,2021 年 9 月,由于卡车司机短缺,英国全科医生 (GP) 的流感疫苗交付延迟了两周。Seqirus(英国最大的流感疫苗供应商)表示,由于“与公路货运延误相关的不可预见的挑战”,疫苗交付中断。中断后,英格兰和威尔士的全科医生被建议重新安排他们的预约。英国卡车司机在 COVID-19 大流行期间返回欧盟并留在那里,这显然是造成经济部门混乱的原因。因此,该国缺乏熟练的卡车司机是导致交付延迟的主要因素,而这反过来又阻碍了市场增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
医疗快递市场:
复合年增长率(2022 - 2030 年)5.2%- 2022 年市场规模
73.1 亿美元 - 2030 年市场规模
109.6 亿美元
市场动态
- 道路交通事故发生率上升,手术数量增加
- 慢性病患病率上升
- 采用轮辐式模型
- 不断增长的战略举措
关键人物;主力;重要一员
- ERS 转型有限公司
- 发送直接有限公司
- 医药物流集团
- 城市打印有限公司
- 联合包裹服务公司
- 联邦快递
- MNX 全球物流
- 瑞莱恩特快递及货运有限公司
- ZIPLINE国际公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 医疗用品和设备
- 血液和器官
- 实验室标本
- 医疗记录
- 其他的
- 国内和国际
- 标准服务、加急和按需服务
- 医院和诊所
- 诊断实验室
- 血液和组织库
- 药店
- 居家支持
- 制药和生物技术公司
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告细分和范围:
医疗快递市场份额根据产品类型、目的地、服务、最终用户和地理位置进行划分。医疗快递市场按产品类型细分为实验室标本、医疗用品和设备、血液和器官、医疗记录等。医疗快递市场按目的地细分为国内和国际。医疗快递市场按服务分为标准服务、加急和按需服务。医疗快递市场按最终用户细分为医院和诊所、诊断实验室、制药和生物技术公司、血库和组织库、家庭支持等。根据地理位置,医疗快递市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚、中国、印度、日本、韩国和亚太其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据产品类型,医疗快递市场细分为实验室标本、医疗用品和设备、血液和器官、医疗笔记等。医疗用品和设备部分在 2022 年占据了最大的市场份额。预计实验室标本部分将在 2022-2030 年期间实现最高的市场复合年增长率。包括消耗品、配件等在内的产品是医疗设施中心反复需要的基本医疗用品。这些医疗用品需要每隔几天在医疗设施中心补充库存。因此,该国对快递服务的需求更大。对于设备,快递服务的选择有限(在设置医疗设施中心时或因损坏而更换时或用高科技设备更换旧设备时)。然而,随着医疗用品需求的日益增长,这一细分市场的医疗快递市场预计将增长更快。此外,该国可能会出现越来越多的医院和其他医疗设施中心。根据英国卫生和社会保健部 2020 年 10 月的公告,英国政府已确认拨款 30 亿美元(37 亿英镑)建设 40 所医院,并有 8 个计划提供资金,到 2030 年建成 48 所医院。因此,预计全球对其他国家的高科技设备和先进医疗用品的需求将增长,同时也将增加该国对快递服务的需求。
许多实验室和医疗机构都有内部配送服务来处理实验室样本。然而,许多实验室和医疗机构中心将独立运输和配送公司提供的医疗物流服务外包。实验室样本是需要温控环境的关键产品。在运输实验室样本时,必须确保安全合规地收集、取货和交付。英国等国家的监管机构发布了各种指南,以确保实验室样本的安全运输。根据牛津大学医院 NHS 基金会信托 2023 年 1 月发布的数据,超过四分之三的医疗诊断依赖于实验室诊断,NHS 每年进行超过 650 万次测试。许多诊断测试是在血液、尿液或其他体液或组织样本上进行的。在这些样本中,一些是常规进行的,一些需要罕见且复杂的诊断测试。因此,需要运输服务的测试被外包给先进的高科技实验室。
按目的地划分,医疗快递市场分为国内和国际。国内部分在 2022 年占据了更大的市场份额,预计国际部分在 2022-2030 年期间的复合年增长率将更高。电子商务公司的增加导致该国物流公司的数量增加。DHL Group、美国联合包裹服务公司、联邦快递公司、爱马仕、皇家邮政、Yodel、DTDC、UPS、Agility 和英国邮政等公司为医疗快递和非医疗快递提供国际服务。其他多家公司通过货运服务提供快递服务,这增加了全球医疗产品的国际快递服务。按服务划分,医疗快递市场分为标准服务和加急和按需服务。标准服务部分在 2022 年占据了更大的市场份额,预计加急和按需服务部分在 2022-2030 年期间的复合年增长率将更高。按最终用户划分,医疗快递市场分为医院和诊所、诊断实验室、制药和生物技术公司、血库和组织库、上门支持等。医院和诊所部分在 2022 年占据了最大的市场份额,而上门支持部分预计将在 2022-2030 年期间实现最高的复合年增长率。
区域分析:
根据地理位置,医疗快递市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。北美是市场增长的最大贡献者,亚太地区是增长最快的地区。北美的医疗快递市场分为美国、加拿大和墨西哥。2022 年,美国在该地区占有最大的市场份额,预计在预测期内将继续占据主导地位。北美医疗快递市场的预计增长归因于器官移植手术数量的增加,这是由于肾脏、肝脏和心脏等器官衰竭病例数量的增加。器官衰竭病例的增加可能与与心脏、肾脏和肝脏相关的慢性疾病患病率激增有关,这刺激了对器官移植的需求。根据器官采购和移植网络的数据,2022 年美国进行了超过 42,800 例器官移植,年增长率约为 3.7%。根据加拿大卫生信息研究所 (CIHI) 的数据,2021 年加拿大进行了约 2,750 例器官移植手术。美国国立卫生研究院 (NIH) 发布的数据显示,2019 年 3 月至 2021 年 2 月期间,墨西哥进行了约 8,500 例移植手术,包括角膜、肾脏、肝脏和心脏。在器官移植过程中,可能需要将器官从一家医院转移到另一家医院。医疗快递业务提供服务,以在适当的储存条件下按时运输这些器官。
医疗快递服务提供商采用重要的患者护理程序,并确保及时高效地运输记录、报告、医疗用品和实验室用品。根据美国劳工统计局的数据,2022 年美国医疗行业雇用了约 18,000 名员工,约占快递行业总就业人数的 4.5%。由于对整体治疗样品和药品的需求不断增长,医疗快递行业的就业人数不断增加,推动了市场的增长。此外,在预测期内,医疗机构的持续技术进步可能会使北美的医疗快递市场受益。2020 年,UPS Flight Forward 与 CVS 合作,将处方药从 CVS 药店运送到佛罗里达州 The Villages,这是美国最大的退休人员社区,拥有超过 135,000 名居民。
医疗快递市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 73.1亿美元 |
2030 年的市场规模 | 109.6亿美元 |
全球复合年增长率(2022 - 2030 年) | 5.2% |
历史数据 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
行业发展和未来机遇:
以下列出了医疗快递市场主要参与者的各种举措:
- 2023 年 1 月,UPS 供应链解决方案 (SCS) 在西班牙马德里开设了新工厂。这座占地 6500 平方米的全新工厂将成为伊比利亚半岛的主要配送点。马德里工厂是 2022 年开设的第 4 家 UPS SCS,鲁尔蒙的新建筑也已揭幕;这些工厂因其中心位置和地面、海洋、铁路和航空连接而被选中,还将容纳欧洲首个 UPS SCS 创新中心。
- 2023 年 2 月,ERS Medical 与 E-zec 合并,以扩大其服务专业知识范围。此次合并将通过结合最佳运营实践、专业知识和高标准为两家公司创造机会。扩大后的业务有望通过为其员工和客户提供更多机会来扩大其业务。此外,合并将为社区中最需要服务的人提供更好的支持。
竞争格局和重点公司:
医疗快递市场中一些知名企业包括 ERS Transition Ltd、Send Direct Ltd、Med Logistics Grp、Citysprint Ltd、United Parcel Services、FedEx Corp、MNX Global Logistics、Reliant Couriers & Haulage Ltd、ZIPLINE International Inc 和德国邮政股份公司。这些公司专注于新产品的推出和地域扩张,以满足全球日益增长的消费者需求,并增加其专业产品组合中的产品范围。它们的全球业务使它们能够服务于大量客户,从而扩大其市场份额。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global medical courier market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the medical courier market during 2022–2030. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
The medical courier market is analyzed on the basis of product type, destination, service type, and end user. Based on product type, the segment is bifurcated into lab specimens, medical supplies and equipment, blood and organs, medical notes, and others. The medical supplies and equipment segment held the largest share of the market in 2022. The segment is anticipated to register the highest CAGR in the market during the forecast period.
The medical courier market majorly consists of the players such as ERS Transition Ltd, Send Direct Ltd, Med Logistics Grp, Citysprint Ltd, United Parcel Services, FedEx Corp, MNX Global Logistics, Reliant Couriers & Haulage Ltd, ZIPLINE International Inc, and Deutsche Post AG.
The growth of the medical courier market in the is estimated to grow owing to key driving factor such as increasing incidence of road accidents and growing number of surgeries and rising prevalence of chronic diseases. However, delay in deliveries due to shortage of skilled truck drivers are hindering the growth of the market during the forecast period.
Medical courier is the supply of samples and equipment related to healthcare and medical requirements can sometimes be urgent and critical. A medical courier allows the movement from one place to another, often from the collection point of a sample, urine, blood, etc., to the healthcare facility centres where the tests are performed. Usually, such samples are time-sensitive and require a prompt transfer between doctors, clinics and hospitals, and biochemistry labs. Medical courier services can be offered across borders with medical test samples, delivery reagents, kits, and more products to research, pharmaceutical, and biotechnology companies. The report covers detailed insights with respect to the services offered by the market players operating in the sector.
The List of Companies - Medical Courier Market
- ERS Transition Ltd
- Send Direct Ltd
- Med Logistics Grp
- Citysprint Ltd
- United Parcel Services
- FedEx Corp
- MNX Global Logistics
- Reliant Couriers & Haulage Ltd
- ZIPLINE International Inc
- Deutsche Post AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.